Schwartz Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-143,149
Closed -$24.4M 130
2018
Q1
$24.4M Sell
143,149
-92,101
-39% -$16.9M 1.44% 25
2017
Q4
$40.9M Sell
235,250
-29,000
-11% -$5.13M 2.42% 11
2017
Q3
$49.3M Hold
264,250
3.08% 4
2017
Q2
$45.5M Sell
264,250
-5,000
-2% -$813K 2.92% 5
2017
Q1
$44.2M Buy
269,250
+5,000
+2% +$831K 2.89% 6
2016
Q4
$38.6M Buy
264,250
+44,000
+20% +$6.62M 2.68% 4
2016
Q3
$36.7M Sell
220,250
-2,500
-1% -$423K 2.62% 6
2016
Q2
$33.9M Buy
222,750
+5,000
+2% +$777K 2.45% 11
2016
Q1
$32.6M Sell
217,750
-450
-0.2% -$66.9K 2.45% 7
2015
Q4
$35.4M Buy
218,200
+50,250
+30% +$7.9M 2.69% 4
2015
Q3
$23.2M Buy
167,950
+107,700
+179% +$17M 1.8% 20
2015
Q2
$9.25M Hold
60,250
0.63% 55
2015
Q1
$9.63M Hold
60,250
0.64% 57
2014
Q4
$9.6M Sell
60,250
-8,250
-12% -$1.29M 0.64% 56
2014
Q3
$9.62M Sell
68,500
-5,100
-7% -$666K 0.69% 45
2014
Q2
$8.71M Hold
73,600
0.62% 58
2014
Q1
$9.08M Hold
73,600
0.67% 54
2013
Q4
$8.4M Sell
73,600
-225
-0.3% -$25.6K 0.63% 64
2013
Q3
$8.26M Buy
73,825
+36,600
+98% +$3.97M 0.7% 57
2013
Q2
$3.67M Buy
+37,225
New +$3.86M 0.37% 89

Other funds holding AMGN

Schwartz Investment Counsel's AMGN Position: Q2 2018 in Review

Schwartz Investment Counsel sold out of Amgen (AMGN) in Q2 2018, closing a stake of 143,149 shares — an estimated $24.4M sold.

Schwartz Investment Counsel first reported a position in AMGN in Q2 2013 and held it in 20 quarters. The position peaked at $49.3M in Q3 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Schwartz Investment Counsel reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Schwartz Investment Counsel sold 143,149 Amgen shares in Q2 2018, an estimated $24.4M.
  • Schwartz Investment Counsel first reported a position in Amgen in Q2 2013 and held it in 20 quarters.
  • Schwartz Investment Counsel's Amgen position peaked at $49.3M in Q3 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Schwartz Investment Counsel's 13F filing for Q2 2018, filed 13 Aug 2018.